It was found that miR-30b-3p inhibition and OV-METTL7B could each reverse the effects of glioma cell viability (Figure 4(a)), migration (Figure 4(b)), invasion (Figure 4(c)), and cell cycle arrest (Figure 4(d)) caused by PDCD4-AS1 knockdown. Here, PDCD4 is linked to glioma.